SEQUENCE LISTING

<110>  Universittsklinikum Regensburg
 
<120>  IL-3 Blockade in Systemic Lupus Erythematosus and Multiple 
       Sclerosis

<130>  U30520WO

<150>  EP 13 005 166.7
<151>  2013-10-31

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  133
<212>  PRT
<213>  Homo sapiens

<400>  1

Ala Pro Met Thr Gln Thr Thr Pro Leu Lys Thr Ser Trp Val Asn Cys 
1               5                   10                  15      


Ser Asn Met Ile Asp Glu Ile Ile Thr His Leu Lys Gln Pro Pro Leu 
            20                  25                  30          


Pro Leu Leu Asp Phe Asn Asn Leu Asn Gly Glu Asp Gln Asp Ile Leu 
        35                  40                  45              


Met Glu Asn Asn Leu Arg Arg Pro Asn Leu Glu Ala Phe Asn Arg Ala 
    50                  55                  60                  


Val Lys Ser Leu Gln Asn Ala Ser Ala Ile Glu Ser Ile Leu Lys Asn 
65                  70                  75                  80  


Leu Leu Pro Cys Leu Pro Leu Ala Thr Ala Ala Pro Thr Arg His Pro 
                85                  90                  95      


Ile His Ile Lys Asp Gly Asp Trp Asn Glu Phe Arg Arg Lys Leu Thr 
            100                 105                 110         


Phe Tyr Leu Lys Thr Leu Glu Asn Ala Gln Ala Gln Gln Thr Thr Leu 
        115                 120                 125             


Ser Leu Ala Ile Phe 
    130             


<210>  2
<211>  4
<212>  PRT
<213>  Homo sapiens

<400>  2

Ser Trp Val Asn 
1               


<210>  3
<211>  22
<212>  PRT
<213>  Homo sapiens

<400>  3

Gln Pro Pro Leu Pro Leu Leu Asp Phe Asn Asn Leu Asn Gly Glu Asp 
1               5                   10                  15      


Gln Asp Ile Leu Met Glu 
            20          


<210>  4
<211>  18
<212>  PRT
<213>  Homo sapiens

<400>  4

Ala Pro Met Thr Gln Thr Thr Pro Leu Lys Thr Ser Trp Val Asn Cys 
1               5                   10                  15      


Ser Asn 
        


<210>  5
<211>  22
<212>  PRT
<213>  Homo sapiens

<400>  5

Thr Phe Tyr Leu Lys Thr Leu Glu Asn Ala Gln Ala Gln Gln Thr Thr 
1               5                   10                  15      


Leu Ser Leu Ala Ile Phe 
            20          


<210>  6
<211>  133
<212>  PRT
<213>  Homo sapiens

<400>  6

Ala Pro Met Thr Gln Thr Thr Ser Leu Lys Thr Ser Trp Val Asn Cys 
1               5                   10                  15      


Ser Asn Met Ile Asp Glu Ile Ile Thr His Leu Lys Gln Pro Pro Leu 
            20                  25                  30          


Pro Leu Leu Asp Phe Asn Asn Leu Asn Gly Glu Asp Gln Asp Ile Leu 
        35                  40                  45              


Met Glu Asn Asn Leu Arg Arg Pro Asn Leu Glu Ala Phe Asn Arg Ala 
    50                  55                  60                  


Val Lys Ser Leu Gln Asn Ala Ser Ala Ile Glu Ser Ile Leu Lys Asn 
65                  70                  75                  80  


Leu Leu Pro Cys Leu Pro Leu Ala Thr Ala Ala Pro Thr Arg His Pro 
                85                  90                  95      


Ile His Ile Lys Asp Gly Asp Trp Asn Glu Phe Arg Arg Lys Leu Thr 
            100                 105                 110         


Phe Tyr Leu Lys Thr Leu Glu Asn Ala Gln Ala Gln Gln Thr Thr Leu 
        115                 120                 125             


Ser Leu Ala Ile Phe 
    130             


<210>  7
<211>  18
<212>  PRT
<213>  Homo sapiens

<400>  7

Ala Pro Met Thr Gln Thr Thr Ser Leu Lys Thr Ser Trp Val Asn Cys 
1               5                   10                  15      


Ser Asn 
        


<210>  8
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Forward Primer (Collagen I)

<400>  8
tgttcagctt tgtggacctc                                                   20


<210>  9
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse Primer (Collagen I)

<400>  9
tcaagcatac ctcgggtttc                                                   20


<210>  10
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Forward Primer (CCL-5)

<400>  10
agcagcaagt gctccaatct                                                   20


<210>  11
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse Primer (CCL-5)

<400>  11
gggaagcgta tacagggtca                                                   20


<210>  12
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Forward Primer (CXCL1)

<400>  12
atccagagct tgaaggtgtt g                                                 21


<210>  13
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse Primer (CXCL1)

<400>  13
gtctgtcttc tttctccgtt actt                                              24


<210>  14
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Forward Primer (beta-Actin)

<400>  14
acccgcgagc acagcttctt tg                                                22


<210>  15
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse Primer (beta-Actin)

<400>  15
acatgccgga gccgttgtcg ac                                                22


5


1


